Publications 2023

Kelly CB, Karanchi H, Yu JY, Leyva MJ, Jenkins AJ, Nankervis AJ, Hanssen KF, Garg SK, Scardo JA, Hammad SM, Aston CE, Beisswenger PJ, Lyons TJ (2023)
Plasma AGE and Oxidation Products, Renal Function, and Preeclampsia in Pregnant Women with Type 1 Diabetes: A Prospective Observational Study
J Diabetes Res, 2023, 8537693
DOI 10.1155/2023/8537693, PubMed 37601831

Krogvold L, Mynarek IM, Ponzi E, Mørk FB, Hessel TW, Roald T, Lindblom N, Westman J, Barker P, Hyöty H, Ludvigsson J, Hanssen KF, Johannesen J, Dahl-Jørgensen K (2023)
Pleconaril and ribavirin in new-onset type 1 diabetes: a phase 2 randomized trial
Nat Med, 29 (11), 2902-2908
DOI 10.1038/s41591-023-02576-1, PubMed 37789144

Publications 2021

Sveen KA, Bech Holte K, Svanteson M, Hanssen KF, Nilsson J, Bengtsson E, Julsrud Berg T (2021)
Autoantibodies Against Methylglyoxal-Modified Apolipoprotein B100 and ApoB100 Peptide Are Associated With Less Coronary Artery Atherosclerosis and Retinopathy in Long-Term Type 1 Diabetes
Diabetes Care, 44 (6), 1402-1409
DOI 10.2337/dc20-2089, PubMed 33858856

Publications 2020

Holte KB, Svanteson M, Hanssen KF, Sveen KA, Seljeflot I, Solheim S, Sell DR, Monnier VM, Berg TJ (2020)
Collagen methionine sulfoxide and glucuronidine/LW-1 are markers of coronary artery disease in long-term survivors with type 1 diabetes. The Dialong study
PLoS One, 15 (5), e0233174
DOI 10.1371/journal.pone.0233174, PubMed 32401813

Kelly CB, Wagner CL, Shary JR, Leyva MJ, Yu JY, Jenkins AJ, Nankervis AJ, Hanssen KF, Garg SK, Scardo JA, Hammad SM, Aston CE, Lyons TJ (2020)
Vitamin D Metabolites and Binding Protein Predict Preeclampsia in Women with Type 1 Diabetes
Nutrients, 12 (7)
DOI 10.3390/nu12072048, PubMed 32664257

Publications 2019

Holte KB, Svanteson M, Hanssen KF, Haig Y, Solheim S, Berg TJ (2019)
Undiagnosed coronary artery disease in long-term type 1 diabetes. The Dialong study
J Diabetes Complications, 33 (5), 383-389
DOI 10.1016/j.jdiacomp.2019.01.006, PubMed 30846232

Kelly CB, Yu JY, Jenkins AJ, Nankervis AJ, Hanssen KF, Garg SK, Scardo JA, Basu A, Hammad SM, Aston CE, Lyons TJ (2019)
Haptoglobin Phenotype Modulates Lipoprotein-Associated Risk for Preeclampsia in Women With Type 1 Diabetes
J Clin Endocrinol Metab, 104 (10), 4743-4755
DOI 10.1210/jc.2019-00723, PubMed 31219590

Publications 2018

Heier M, Espeland CN, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Fugelseth D, Dahl-Jørgensen K (2018)
Preserved endothelial function in young adults with type 1 diabetes
PLoS One, 13 (10), e0206523
DOI 10.1371/journal.pone.0206523, PubMed 30359432

Heier M, Stensæth KH, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Dahl-Jørgensen K (2018)
Increased arterial stiffness in childhood onset diabetes: a cardiovascular magnetic resonance study
Eur Heart J Cardiovasc Imaging, 19 (6), 694-700
DOI 10.1093/ehjci/jex178, PubMed 28950341

Henriksen T, Jenum AK, Thordarson HB, Holm HO, Gudim HB, Hanssen KF (2018)
[Not Available]
Tidsskr Nor Laegeforen, 138 (10)
DOI 10.4045/tidsskr.18.0430, PubMed 29893096

Henriksen T, Jenum AK, Thordarson HB, Holm HO, Gudim HB, Hanssen KF (2018)
Little use in the criticism of the guidelines for gestational diabetes
Tidsskr. Nor. Laegeforen., 138 (10), 894

Holm LJ, Krogvold L, Hasselby JP, Kaur S, Claessens LA, Russell MA, Mathews CE, Hanssen KF, Morgan NG, Koeleman BPC, Roep BO, Gerling IC, Pociot F, Dahl-Jørgensen K, Buschard K (2018)
Abnormal islet sphingolipid metabolism in type 1 diabetes
Diabetologia, 61 (7), 1650-1661
DOI 10.1007/s00125-018-4614-2, PubMed 29671030

Kelly CB, Hookham MB, Yu JY, Jenkins AJ, Nankervis AJ, Hanssen KF, Garg SK, Scardo JA, Hammad SM, Menard MK, Aston CE, Lyons TJ (2018)
Response to Comment on Kelly et al. Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes. Diabetes Care 2018;41:120-127
Diabetes Care, 41 (6), e102-e103
DOI 10.2337/dci18-0006, PubMed 29784706

Kuric E, Krogvold L, Hanssen KF, Dahl-Jørgensen K, Skog O, Korsgren O (2018)
No Evidence for Presence of Mucosal-Associated Invariant T Cells in the Insulitic Lesions in Patients Recently Diagnosed with Type 1 Diabetes
Am J Pathol, 188 (8), 1744-1748
DOI 10.1016/j.ajpath.2018.04.009, PubMed 29803829

Publications 2017

Atar D, Hanssen KF (2017)
Type 2 Diabetes and Heart Failure - More Scrutiny Wanted!
Cardiology, 139 (1), 37-39
DOI 10.1159/000484345, PubMed 29186706

Brunvand L, Heier M, Brunborg C, Hanssen KF, Fugelseth D, Stensaeth KH, Dahl-Jørgensen K, Margeirsdottir HD (2017)
Advanced glycation end products in children with type 1 diabetes and early reduced diastolic heart function
BMC Cardiovasc Disord, 17 (1), 133
DOI 10.1186/s12872-017-0551-0, PubMed 28545398

Heier M, Borja MS, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Dahl-Jørgensen K, Oda MN (2017)
Reduced HDL function in children and young adults with type 1 diabetes
Cardiovasc Diabetol, 16 (1), 85
DOI 10.1186/s12933-017-0570-2, PubMed 28683835

Holte KB, Juel NG, Brox JI, Hanssen KF, Fosmark DS, Sell DR, Monnier VM, Berg TJ (2017)
Hand, shoulder and back stiffness in long-term type 1 diabetes; cross-sectional association with skin collagen advanced glycation end-products. The Dialong study
J Diabetes Complications, 31 (9), 1408-1414
DOI 10.1016/j.jdiacomp.2017.06.007, PubMed 28705609

Kelly CB, Hookham MB, Yu JY, Jenkins AJ, Nankervis AJ, Hanssen KF, Garg SK, Scardo JA, Hammad SM, Menard MK, Aston CE, Lyons TJ (2017)
Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes
Diabetes Care, 41 (1), 120-127
DOI 10.2337/dc17-1635, PubMed 29122892

Kelly CB, Hookham MB, Yu JY, Lockhart SM, Du M, Jenkins AJ, Nankervis A, Hanssen KF, Henriksen T, Garg SK, Hammad SM, Scardo JA, Aston CE, Patterson CC, Lyons TJ (2017)
Circulating adipokines are associated with pre-eclampsia in women with type 1 diabetes
Diabetologia, 60 (12), 2514-2524
DOI 10.1007/s00125-017-4415-z, PubMed 28875223

Kuric E, Seiron P, Krogvold L, Edwin B, Buanes T, Hanssen KF, Skog O, Dahl-Jørgensen K, Korsgren O (2017)
Demonstration of Tissue Resident Memory CD8 T Cells in Insulitic Lesions in Adult Patients with Recent-Onset Type 1 Diabetes
Am J Pathol, 187 (3), 581-588
DOI 10.1016/j.ajpath.2016.11.002, PubMed 28212742

Publications 2016

Hanssen KF (2016)
National guidelines in Endocrinology
Tidsskr. Nor. Laegeforen., 136 (11), 1020
DOI 10.4045/tidsskr.16.0291

Publications 2015

Basu A, Yu JY, Jenkins AJ, Nankervis AJ, Hanssen KF, Henriksen T, Lorentzen B, Garg SK, Menard MK, Hammad SM, Scardo JA, Aston CE, Lyons TJ (2015)
Trace elements as predictors of preeclampsia in type 1 diabetic pregnancy
Nutr Res, 35 (5), 421-30
DOI 10.1016/j.nutres.2015.04.004, PubMed 25912764

Heier M, Margeirsdottir HD, Gaarder M, Stensæth KH, Brunborg C, Torjesen PA, Seljeflot I, Hanssen KF, Dahl-Jørgensen K (2015)
Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study
Cardiovasc Diabetol, 14, 126
DOI 10.1186/s12933-015-0292-2, PubMed 26408307

Heier M, Margeirsdottir HD, Torjesen PA, Seljeflot I, Stensæth KH, Gaarder M, Brunborg C, Hanssen KF, Dahl-Jørgensen K (2015)
The advanced glycation end product methylglyoxal-derived hydroimidazolone-1 and early signs of atherosclerosis in childhood diabetes
Diab Vasc Dis Res, 12 (2), 139-45
DOI 10.1177/1479164114560910, PubMed 25616705

Krogvold L, Skog O, Sundström G, Edwin B, Buanes T, Hanssen KF, Ludvigsson J, Grabherr M, Korsgren O, Dahl-Jørgensen K (2015)
Function of Isolated Pancreatic Islets From Patients at Onset of Type 1 Diabetes: Insulin Secretion Can Be Restored After Some Days in a Nondiabetogenic Environment In Vitro: Results From the DiViD Study
Diabetes, 64 (7), 2506-12
DOI 10.2337/db14-1911, PubMed 25677915

Krogvold L, Wiberg A, Edwin B, Buanes T, Jahnsen FL, Hanssen KF, Larsson E, Korsgren O, Skog O, Dahl-Jørgensen K (2015)
Insulitis and characterisation of infiltrating T cells in surgical pancreatic tail resections from patients at onset of type 1 diabetes
Diabetologia, 59 (3), 492-501
DOI 10.1007/s00125-015-3820-4, PubMed 26602422

Publications 2014

Eidem I, Vangen S, Henriksen T, Vollset SE, Hanssen KF, Joner G, Stene LC (2014)
Discrepancy in term calculation from second trimester ultrasound scan versus last menstrual period in women with type 1 diabetes
Acta Obstet Gynecol Scand, 93 (8), 809-16
DOI 10.1111/aogs.12422, PubMed 24807126

Heier M, Margeirsdottir HD, Brunborg C, Hanssen KF, Dahl-Jørgensen K, Seljeflot I (2014)
Inflammation in childhood type 1 diabetes; influence of glycemic control
Atherosclerosis, 238 (1), 33-7
DOI 10.1016/j.atherosclerosis.2014.11.018, PubMed 25437887

Krogvold L, Edwin B, Buanes T, Frisk G, Skog O, Anagandula M, Korsgren O, Undlien D, Eike MC, Richardson SJ, Leete P, Morgan NG, Oikarinen S, Oikarinen M, Laiho JE, Hyöty H, Ludvigsson J, Hanssen KF, Dahl-Jørgensen K (2014)
Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes
Diabetes, 64 (5), 1682-7
DOI 10.2337/db14-1370, PubMed 25422108

Krogvold L, Edwin B, Buanes T, Ludvigsson J, Korsgren O, Hyöty H, Frisk G, Hanssen KF, Dahl-Jørgensen K (2014)
Pancreatic biopsy by minimal tail resection in live adult patients at the onset of type 1 diabetes: experiences from the DiViD study
Diabetologia, 57 (4), 841-3
DOI 10.1007/s00125-013-3155-y, PubMed 24429579

Sveen KA, Dahl-Jørgensen K, Stensaeth KH, Angel K, Seljeflot I, Sell DR, Monnier VM, Hanssen KF (2014)
Glucosepane and oxidative markers in skin collagen correlate with intima media thickness and arterial stiffness in long-term type 1 diabetes
J Diabetes Complications, 29 (3), 407-12
DOI 10.1016/j.jdiacomp.2014.12.011, PubMed 25600701

Sveen KA, Nerdrum T, Hanssen KF, Brekke M, Torjesen PA, Strauch CM, Sell DR, Monnier VM, Dahl-Jørgensen K, Steine K (2014)
Impaired left ventricular function and myocardial blood flow reserve in patients with long-term type 1 diabetes and no significant coronary artery disease: associations with protein glycation
Diab Vasc Dis Res, 11 (2), 84-91
DOI 10.1177/1479164113518805, PubMed 24443481

Publications 2013

Du M, Basu A, Fu D, Wu M, Centola M, Jenkins AJ, Hanssen KF, Garg SK, Hammad SM, Scardo JA, Aston CE, Lyons TJ (2013)
Serum inflammatory markers and preeclampsia in type 1 diabetes: a prospective study
Diabetes Care, 36 (7), 2054-61
DOI 10.2337/dc12-1934, PubMed 23393212

Sveen KA, Karimé B, Jørum E, Mellgren SI, Fagerland MW, Monnier VM, Dahl-Jørgensen K, Hanssen KF (2013)
Small- and large-fiber neuropathy after 40 years of type 1 diabetes: associations with glycemic control and advanced protein glycation: the Oslo Study
Diabetes Care, 36 (11), 3712-7
DOI 10.2337/dc13-0788, PubMed 24026557

Publications 2012

Basu A, Alaupovic P, Wu M, Jenkins AJ, Yu Y, Nankervis AJ, Hanssen KF, Scholz H, Henriksen T, Lorentzen B, Clausen T, Garg SK, Menard MK, Hammad SM, Scardo JA, Stanley JR, Dashti A, Aston CE, Lyons TJ (2012)
Plasma lipoproteins and preeclampsia in women with type 1 diabetes: a prospective study
J Clin Endocrinol Metab, 97 (5), 1752-62
DOI 10.1210/jc.2011-3255, PubMed 22438226

Eidem I, Vangen S, Hanssen KF, Vollset SE, Henriksen T, Joner G, Stene LC (2012)
Perinatal and Infant Mortality in Term and Preterm Births Among Women With Type 1 Diabetes EDITORIAL COMMENT
Obstet. Gynecol. Surv., 67 (3), 139-141
DOI 10.1097/OGX.0b013e31824b6f5f

Fraser DA, Diep LM, Hovden IA, Nilsen KB, Sveen KA, Seljeflot I, Hanssen KF (2012)
The effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial
Diabetes Care, 35 (5), 1095-7
DOI 10.2337/dc11-1895, PubMed 22446172

Fraser DA, Diep LM, Hovden IA, Nilsen KB, Sveen KA, Seljeflot I, Hanssen KF (2012)
Response to Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095-1097
Diabetes Care, 35 (11), E80
DOI 10.2337/dc12-1124

Hanssen KF (2012)
[Physicians and drug industry]
Tidsskr Nor Laegeforen, 132 (4), 386-7
DOI 10.4045/tidsskr.12.0036, PubMed 22353819

Yu Y, Hanssen KF, Kalyanaraman V, Chirindel A, Jenkins AJ, Nankervis AJ, Torjesen PA, Scholz H, Henriksen T, Lorentzen B, Garg SK, Menard MK, Hammad SM, Scardo JA, Stanley JR, Wu M, Basu A, Aston CE, Lyons TJ (2012)
Reduced soluble receptor for advanced glycation end-products (sRAGE) scavenger capacity precedes pre-eclampsia in Type 1 diabetes
BJOG, 119 (12), 1512-20
DOI 10.1111/j.1471-0528.2012.03463.x, PubMed 22900949

Publications 2011

Azar M, Basu A, Jenkins AJ, Nankervis AJ, Hanssen KF, Scholz H, Henriksen T, Garg SK, Hammad SM, Scardo JA, Aston CE, Lyons TJ (2011)
Serum carotenoids and fat-soluble vitamins in women with type 1 diabetes and preeclampsia: a longitudinal study
Diabetes Care, 34 (6), 1258-64
DOI 10.2337/dc10-2145, PubMed 21498785

Berg JP, Hanssen KF, Bjerve KS, Claudi T, Dahl-Jørgensen K, Rustad P, Sandberg S, Skrivarhaug T (2011)
[Standardized hemoglobin A1C for diagnostic use?]
Tidsskr Nor Laegeforen, 131 (6), 565-6
DOI 10.4045/tidsskr.10.1160, PubMed 21423304

Eidem I, Vangen S, Hanssen KF, Vollset SE, Henriksen T, Joner G, Stene LC (2011)
Perinatal and infant mortality in term and preterm births among women with type 1 diabetes
Diabetologia, 54 (11), 2771-8
DOI 10.1007/s00125-011-2281-7, PubMed 21866407

Fraser DA, Hessvik NP, Nikolić N, Aas V, Hanssen KF, Bøhn SK, Thoresen GH, Rustan AC (2011)
Benfotiamine increases glucose oxidation and downregulates NADPH oxidase 4 expression in cultured human myotubes exposed to both normal and high glucose concentrations
Genes Nutr, 7 (3), 459-69
DOI 10.1007/s12263-011-0252-8, PubMed 21984258

Lund T, Svindland A, Pepaj M, Jensen AB, Berg JP, Kilhovd B, Hanssen KF (2011)
Fibrin(ogen) may be an important target for methylglyoxal-derived AGE modification in elastic arteries of humans
Diab Vasc Dis Res, 8 (4), 284-94
DOI 10.1177/1479164111416831, PubMed 21844128

Publications 2010

Eidem I, Stene LC, Henriksen T, Hanssen KF, Vangen S, Vollset SE, Joner G (2010)
Congenital anomalies in newborns of women with type 1 diabetes: nationwide population-based study in Norway, 1999-2004
Acta Obstet Gynecol Scand, 89 (11), 1403-11
DOI 10.3109/00016349.2010.518594, PubMed 20929418

Ørbo A, Moe BT, Arnes M, Pettersen I, Larsen K, Eggen T, Myrmel K, Hanssen K (2010)
Prognostic markers for detection of coexistent carcinoma in high-risk endometrial hyperplasia
Anticancer Res, 30 (11), 4649-55
PubMed 21115919

Publications 2009

Bangstad HJ, Seljeflot I, Berg TJ, Hanssen KF (2009)
Renal tubulointerstitial expansion is associated with endothelial dysfunction and inflammation in type 1 diabetes
Scand J Clin Lab Invest, 69 (1), 138-44
DOI 10.1080/00365510802444080, PubMed 18846477

Kilhovd BK, Juutilainen A, Lehto S, Rönnemaa T, Torjesen PA, Hanssen KF, Laakso M (2009)
Increased serum levels of methylglyoxal-derived hydroimidazolone-AGE are associated with increased cardiovascular disease mortality in nondiabetic women
Atherosclerosis, 205 (2), 590-4
DOI 10.1016/j.atherosclerosis.2008.12.041, PubMed 19185865

Thorsby PM, Midthjell K, Gjerlaugsen N, Holmen J, Hanssen KF, Birkeland KI, Berg JP (2009)
Comparison of genetic risk in three candidate genes (TCF7L2, PPARG, KCNJ11) with traditional risk factors for type 2 diabetes in a population-based study--the HUNT study
Scand J Clin Lab Invest, 69 (2), 282-7
DOI 10.1080/00365510802538188, PubMed 18972257

Aas AM, Hanssen KF, Berg JP, Thorsby PM, Birkeland KI (2009)
Insulin-stimulated increase in serum leptin levels precedes and correlates with weight gain during insulin therapy in type 2 diabetes
J Clin Endocrinol Metab, 94 (8), 2900-6
DOI 10.1210/jc.2008-1005, PubMed 19509109

Publications 2008

Fosmark DS, Berg JP, Jensen AB, Sandvik L, Agardh E, Agardh CD, Hanssen KF (2008)
Increased retinopathy occurrence in type 1 diabetes patients with increased serum levels of the advanced glycation endproduct hydroimidazolone
Acta Ophthalmol, 87 (5), 498-500
DOI 10.1111/j.1755-3768.2008.01300.x, PubMed 18631328

Harsem NK, Braekke K, Torjussen T, Hanssen K, Staff AC (2008)
Advanced glycation end products in pregnancies complicated with diabetes mellitus or preeclampsia
Hypertens Pregnancy, 27 (4), 374-86
DOI 10.1080/10641950802000968, PubMed 19003638

Holan S, Vangen S, Hanssen K, Stray-Pedersen B (2008)
[Pregnancy in diabetes among Asian, African and Norwegian women]
Tidsskr Nor Laegeforen, 128 (11), 1289-92
PubMed 18511973

Yu Y, Jenkins AJ, Nankervis AJ, Hanssen KF, Scholz H, Henriksen T, Lorentzen B, Clausen T, Garg SK, Menard MK, Hammad SM, Scardo JC, Stanley JR, Dashti A, May K, Lu K, Aston CE, Wang JJ, Zhang SX, Ma JX, Lyons TJ (2008)
Anti-angiogenic factors and pre-eclampsia in type 1 diabetic women
Diabetologia, 52 (1), 160-8
DOI 10.1007/s00125-008-1182-x, PubMed 18985316

Publications 2007

Christophersen Y, Hanssen KF (2007)
Diabetes for livet: aldri fred å få?
Y. Christophersen, [Gjettum] (2. oppl.), 224 s.
BIBSYS 070634742, ISBN 978-82-996870-1-0

Fosmark DS, Bragadóttir R, Stene-Johansen I, Berg JP, Berg TJ, Lund T, Sandvik L, Hanssen KF (2007)
Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study
Acta Ophthalmol Scand, 85 (6), 618-22
DOI 10.1111/j.1600-0420.2007.00913.x, PubMed 17488318

Kilhovd BK, Juutilainen A, Lehto S, Rönnemaa T, Torjesen PA, Hanssen KF, Laakso M (2007)
Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up study
Diabetologia, 50 (7), 1409-17
DOI 10.1007/s00125-007-0687-z, PubMed 17479244

Larsen JR, Tsunoda T, Tuzcu EM, Schoenhagen P, Brekke M, Arnesen H, Hanssen KF, Nissen SE, Dahl-Jorgensen K (2007)
Intracoronary ultrasound examinations reveal significantly more advanced coronary atherosclerosis in people with type 1 diabetes than in age- and sex-matched non-diabetic controls
Diab Vasc Dis Res, 4 (1), 62-5
DOI 10.3132/dvdr.2007.009, PubMed 17469046

Publications 2006

Chawla A, Amundsen AL, Hanssen KF, Iversen PO (2006)
[Gestational diabetes in women from South Asia]
Tidsskr Nor Laegeforen, 126 (8), 1041-3
PubMed 16619062

Fosmark DS, Torjesen PA, Kilhovd BK, Berg TJ, Sandvik L, Hanssen KF, Agardh CD, Agardh E (2006)
Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus
Metabolism, 55 (2), 232-6
DOI 10.1016/j.metabol.2005.08.017, PubMed 16423631

Seljeflot I, Larsen JR, Dahl-Jørgensen K, Hanssen KF, Arnesen H (2006)
Fibrinolytic activity is highly influenced by long-term glycemic control in Type 1 diabetic patients
J Thromb Haemost, 4 (3), 686-8
DOI 10.1111/j.1538-7836.2006.01803.x, PubMed 16460457

Skrivarhaug T, Bangstad HJ, Stene LC, Sandvik L, Hanssen KF, Joner G (2006)
Low risk of overt nephropathy after 24 yr of childhood-onset type 1 diabetes mellitus (T1DM) in Norway
Pediatr Diabetes, 7 (5), 239-46
DOI 10.1111/j.1399-5448.2006.00204.x, PubMed 17054444

Skrivarhaug T, Fosmark DS, Stene LC, Bangstad HJ, Sandvik L, Hanssen KF, Joner G (2006)
Low cumulative incidence of proliferative retinopathy in childhood-onset type 1 diabetes: a 24-year follow-up study
Diabetologia, 49 (10), 2281-90
DOI 10.1007/s00125-006-0364-7, PubMed 16955208

Publications 2005

Dahl-Jørgensen K, Larsen JR, Hanssen KF (2005)
Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment?
Diabetologia, 48 (8), 1445-53
DOI 10.1007/s00125-005-1832-1, PubMed 15971059

Kilhovd BK, Juutilainen A, Lehto S, Rönnemaa T, Torjesen PA, Birkeland KI, Berg TJ, Hanssen KF, Laakso M (2005)
High serum levels of advanced glycation end products predict increased coronary heart disease mortality in nondiabetic women but not in nondiabetic men: a population-based 18-year follow-up study
Arterioscler Thromb Vasc Biol, 25 (4), 815-20
DOI 10.1161/01.ATV.0000158380.44231.fe, PubMed 15692098

Larsen JR, Brekke M, Bergengen L, Sandvik L, Arnesen H, Hanssen KF, Dahl-Jorgensen K (2005)
Mean HbA1c over 18 years predicts carotid intima media thickness in women with type 1 diabetes
Diabetologia, 48 (4), 776-9
DOI 10.1007/s00125-005-1700-z, PubMed 15759107

Skrivarhaug T, Bangstad HJ, Stene LC, Sandvik L, Hanssen KF, Joner G (2005)
Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway
Diabetologia, 49 (2), 298-305
DOI 10.1007/s00125-005-0082-6, PubMed 16365724

Publications 2004

Christophersen Y, Hanssen KF (2004)
Diabetes for livet: aldri fred å få?
Y. Christophersen, [Gjettum], 224 s.
BIBSYS 041101057, ISBN 82-996870-0-4

Hanssen KF (2004)
Type 2 diabetes er flere sykdommer
In Diabeteshåndboken, Gyldendal akademisk, Oslo, s. 36-41
BIBSYS 041953363

Hanssen KF (2004)
Diabetisk ketoacidose og non-ketotisk ukontrollert diabetes
In Diabeteshåndboken, Gyldendal akademisk, Oslo, s. 182-185
BIBSYS 041964861

Hanssen KF (2004)
Graviditet og diabetes - en viktig terapeutisk utfordring
In Diabeteshåndboken, Gyldendal akademisk, Oslo, s. 284-288
BIBSYS 041965418

Larsen JR, Sjøholm H, Berg TJ, Sandvik L, Brekke M, Hanssen KF, Dahl-Jørgensen K (2004)
Eighteen years of fair glycemic control preserves cardiac autonomic function in type 1 diabetes
Diabetes Care, 27 (4), 963-6
DOI 10.2337/diacare.27.4.963, PubMed 15047656

Larsen JR, Sjøholm H, Berg TJ, Sandvik L, Brekke M, Hanssen KF, Dahl-Jørgensen K (2004)
Eighteen years of fair glycemic control preserves cardiacautonomic function in type 1 diabetes
In Diabetes care, The Association, Alexandria, VA, 27(2004)4, S. 963-6
BIBSYS 05180686x

Publications 2003

Birkeland KI, Kilhovd B, Thorsby P, Torjesen PA, Ganss R, Vaaler S, Hanssen KF (2003)
Heterogeneity of non-insulin-dependent diabetes expressed as variability in insulin sensitivity, beta-cell function and cardiovascular risk profile
Diabet Med, 20 (1), 37-45
DOI 10.1046/j.1464-5491.2003.00838.x, PubMed 12519318

Birkeland KI, Kilhovd BK, Thorsby P, Torjesen PA, Ganss R, Vaaler S, Hanssen KF (2003)
Heterogeneity of non-insulin-dependent diabetes expressedas variability in insulin sensitivity, beta-cell function and cardiovascular risk profile
In Diabetic medicine, John Wiley, Chichester, 20(2003)1, s.37-45
BIBSYS 04170732x

Hanssen KF (2003)
[Lactic acidosis as adverse effect of metformin]
Tidsskr Nor Laegeforen, 123 (18), 2583-4
PubMed 14714049

Hanssen KF (2003)
Type 1 diabetes gjennom 80 år
In Diabetes, Diabetesforbundet, Oslo, 54(2003)1, s.39
BIBSYS 041715500

Hanssen KF (2003)
Kombinasjonsbehandling ved type 2 diabetes
In Diabetes, Diabetesforbundet, Oslo, 54(2003)2, s.42
BIBSYS 04171556x

Hanssen KF (2003)
Nytt håp for type 2: betacellen kan vekkes?
In Diabetes, Diabetesforbundet, Oslo, 54(2003)4, s.59
BIBSYS 041715659

Hanssen KF (2003)
GLP-1: den nye vidundermedisin
In Diabetes, Diabetesforbundet, Oslo, 54(2003)6, s.40
BIBSYS 041715829

Kilhovd BK, Giardino I, Torjesen PA, Birkeland KI, Berg TJ, Thornalley PJ, Brownlee M, Hanssen KF (2003)
Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes
Metabolism, 52 (2), 163-7
DOI 10.1053/meta.2003.50035, PubMed 12601626

Kilhovd BK, Giardino I, Torjesen PA, Birkeland KI, Berg TJ, Thornalley PJ, Brownlee M, Hanssen KF (2003)
Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes
In Metabolism, Grune & Stratton, New York, 52(2003)2, s.163-7
BIBSYS 041719271

Larsen J, Bergengen L, Sandvik L, Arnesen H, Hanssen KF, Dahl-Jørgensen K (2003)
Mean HbA1c during 18 years predicts common cartoid arteryintima-media thickness in women with diabetes type 1
In Diabetes, The Association, New York, 52(2003)suppl 1, s.P687
BIBSYS 041734599

Larsen JR, Sjoholm H, Hanssen KF, Sandvik L, Berg TJ, Dahl-Jorgensen K (2003)
Optimal blood glucose control during 18 years preserves peripheral nerve function in patients with 30 years' duration of type 1 diabetes
Diabetes Care, 26 (8), 2400-4
DOI 10.2337/diacare.26.8.2400, PubMed 12882869

Larsen JR, Sjøholm H, Hanssen KF, Sandvik K, Berg TJ, Dahl-Jørgensen K (2003)
Optimal blood glucose control during 18 years preserves peripheral nerve function in patients with 30 years' duration of type 1 diabetes
In Diabetes care, The Association, Alexandria, VA, 26(2003)8, s.2400-4
BIBSYS 041719344

Thorsby PM, Blekastad I, Sletmo R, Hanssen KF, Birkeland KI (2003)
Non-glucose stimulated early insulin secretion is presenteven after long duration of type 2 diabetes
In Diabetologia, Springer, Berlin, 46(2003)suppl 2, s.A168 abstract 478
BIBSYS 041735986

Publications 2002

Bangstad HJ, Østerby R, Rudberg S, Hartmann A, Brabrand K, Hanssen KF (2002)
Kidney function and glomerulopathy over 8 years in young patients with Type I (insulin-dependent) diabetes mellitus and microalbuminuria
Diabetologia, 45 (2), 253-61
DOI 10.1007/s00125-001-0744-y, PubMed 11935157

Hanssen K (2002)
Ingesting menstrual blood: Notions of health and bodily fluids in Bengal
Ethnology, 41 (4), 365-379
DOI 10.2307/4153014

Larsen J, Brekke M, Sandvik L, Arnesen H, Hanssen KF, Dahl-Jorgensen K (2002)
Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control
Diabetes, 51 (8), 2637-41
DOI 10.2337/diabetes.51.8.2637, PubMed 12145181

Publications 2001

Bangstad HJ, Østerby R, Rudberg S, Hartmann A, Hanssen KF (2001)
The progression of glomerulopathy during 8 years in youngpatients with Type 1 diabetes and microalbuminuria
In Diabetologia, Springer, Berlin, 44(2001)suppl 1, s.A270 Abstrakt nr 1034
BIBSYS 022034005

Hanssen KF (2001)
Acute metabolic complications in diabetes mellitus
In Endocrinology and metabolism, McGraw-Hill, London, 2001, s.615-618
BIBSYS 022030468

Hanssen KF (2001)
Management of type 1 diabetes
In Endocrinology and metabolism, McGraw-Hill, London, 2001, s.603-606
BIBSYS 022030484

Hanssen KF (2001)
Spennende forskning
In Diabetes for helsepersonell, Norges diabetesforbund, Oslo, 16(2001)Startmagasin, s.28-29
BIBSYS 022031928

Hanssen KF (2001)
Forskning i fugleperspektiv
In Diabetes, Diabetesforbundet, Oslo, 52(2001)nr 3, s.10-11
BIBSYS 02203272x

Hanssen KF (2001)
Nye langsomtvirkende insuliner
In Diabetes for helsepersonell, Norges diabetesforbund, Oslo, 16(2001)nr 2, s.9-10
BIBSYS 022032754

Hanssen KF (2001)
Diabetes type 2 kan forebygges - helt sikkert
In Diabetes, Diabetesforbundet, Oslo, 52(2001)nr 4, s.22
BIBSYS 022032827

Hanssen KF (2001)
Kan D-vitamin forebygge type 1-diabetes?
In Diabetes, Diabetesforbundet, Oslo, 52(2001)nr 7, s.43
BIBSYS 022033041

Larsen JR, Brekke M, Sandvik L, Hanssen KF, Dahl-Jørgensen K (2001)
Glycohemoglobin values over 18 years predict coronary atheromatosis in type 1 diabetics
In Diabetologia, Springer, Berlin, 44(2001)suppl 1, s.A46 Abstrakt nr 175
BIBSYS 02203546x

Publications 2000

Birkeland KI, Claudi T, Hansteen V, Hanssen KF, Hjermann I, Jenssen T, Jervell J, Os I (2000)
[Prevention of cardiovascular disease in type 2 diabetes]
Tidsskr Nor Laegeforen, 120 (21), 2554-9
PubMed 11070996

Birkeland KI, Claudi T, Hansteen V, Hanssen KF, Jenssen T, Jervell JA, Os I (2000)
Forebygging av hjerte- og karsykdom ved type 2-diabetes
In Tidsskrift for Den norske legeforening, Foreningen, Oslo, 120(2000)nr. 21, S. 2554-2559
BIBSYS 010758151

Grill V, Claudi T, Følling I, Hanssen KF, Jervell JA, Jenssen T (2000)
Nye diagnostiske kriterier for diabetes mellitus - hvorfor?
In Tidsskrift for Den norske legeforening, Foreningen, Oslo, 120(2000)nr. 16, S. 1876-1877
BIBSYS 010758143

Grill V, Claudi T, Følling I, Jenssen T, Hanssen K, Jervell J (2000)
[New diagnostic criteria for diabetes mellitus--why?]
Tidsskr Nor Laegeforen, 120 (16), 1876-7
PubMed 10925616

Hanssen KF (2000)
30 spørsmål og svar om svangerskap og type 1 diabetes
Eli Lilly Norge, [Oslo], 18 s.
BIBSYS 010869344

Hanssen KF, Berg TJ (2000)
[Changing treatment of diabetes]
Tidsskr Nor Laegeforen, 120 (20), 2377
PubMed 11475217

Hanssen KF, Berg TJ (2000)
Diabetesbehandling i forandring
In Tidsskrift for Den norske legeforening, Foreningen, Oslo, 120(2001)nr. 20, S. 2377
BIBSYS 022063064

Kilhovd B, Giardino I, Torjesen PA, Birkeland KI, Thornalley PJ, Brownlee M, Hanssen KF (2000)
Increased serum methylglyoxal-derived hydroimidazolone inpatients with type 2 diabetes
In Diabetologia, Springer, Berlin, 43(2000)Suppl.1, s.A53 210
BIBSYS 01078408x

Kilhovd B, Giardino I, Torjesen PA, Birkeland KI, Thornalley PJ, Brownlee M, Hanssen KF (2000)
Increased serum methylglyoxal-derived hydroimidazolone inpatients with type 2 diabetes
In European journal of endocrinology, Supplementum, BioScientifica Ltd., Bristol, 142(2000)Suppl 1, s.26
BIBSYS 010890785

Rosenfalck AM, Thorsby P, Kjems L, Birkeland K, Dejgaard A, Hanssen KF, Madsbad S (2000)
Improved postprandial glycaemic control with insulin Aspart in type 2 diabetic patients treated with insulin
Acta Diabetol, 37 (1), 41-6
DOI 10.1007/s005920070034, PubMed 10928235

Publications 1999

Bangstad HJ, Osterby R, Hartmann A, Berg TJ, Hanssen KF (1999)
Severity of glomerulopathy predicts long-term urinary albumin excretion rate in patients with type 1 diabetes and microalbuminuria
Diabetes Care, 22 (2), 314-9
DOI 10.2337/diacare.22.2.314, PubMed 10333951

Berg TJ, Snorgaard O, Faber J, Torjesen PA, Hildebrandt P, Mehlsen J, Hanssen KF (1999)
Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes
Diabetes Care, 22 (7), 1186-90
DOI 10.2337/diacare.22.7.1186, PubMed 10388987

Kilhovd BK, Berg TJ, Birkeland KI, Thorsby P, Hanssen KF (1999)
Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease
Diabetes Care, 22 (9), 1543-8
DOI 10.2337/diacare.22.9.1543, PubMed 10480523

Publications 1998

Berg TJ, Clausen JT, Torjesen PA, Dahl-Jørgensen K, Bangstad HJ, Hanssen KF (1998)
The advanced glycation end product Nepsilon-(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes
Diabetes Care, 21 (11), 1997-2002
DOI 10.2337/diacare.21.11.1997, PubMed 9802757

Berg TJ, Nourooz-Zadeh J, Wolff SP, Tritschler HJ, Bangstad HJ, Hanssen KF (1998)
Hydroperoxides in plasma are reduced by intensified insulin treatment. A randomized controlled study of IDDM patients with microalbuminuria
Diabetes Care, 21 (8), 1295-300
DOI 10.2337/diacare.21.8.1295, PubMed 9702436

Furuseth K, Berg K, Hanssen KF, Rutle O, Bruusgaard D, Vaaler S (1998)
Serum lipoprotein(a) and cardiovascular disease in non-insulin-dependent diabetes mellitus
Scand J Prim Health Care, 16 (1), 40-3
DOI 10.1080/028134398750003395, PubMed 9612878

Hanssen K (1998)
Modernisation of the processing industry in Finnmark: Impacts of formal education and the challenge for resource management
NORTHERN WATERS: MANAGEMENT ISSUES AND PRACTICE, 103-115

Hanssen KF, Birkeland KI, Thorsby P (1998)
[Type 2-diabetes consists of several diseases]
Tidsskr Nor Laegeforen, 118 (7), 1025
PubMed 9531820

Publications 1997

Berg TJ, Bangstad HJ, Torjesen PA, Osterby R, Bucala R, Hanssen KF (1997)
Advanced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitus
Metabolism, 46 (6), 661-5
DOI 10.1016/s0026-0495(97)90010-x, PubMed 9186302

Berg TJ, Dahl-Jørgensen K, Torjesen PA, Hanssen KF (1997)
Increased serum levels of advanced glycation end products (AGEs) in children and adolescents with IDDM
Diabetes Care, 20 (6), 1006-8
DOI 10.2337/diacare.20.6.1006, PubMed 9167115

Bollerslev J, Jervell J, Hanssen K, Børdahl PE, Henriksen T, Moe N (1997)
[So called diabetes in pregnancy--a new public disease?]
Tidsskr Nor Laegeforen, 117 (14), 2074-5
PubMed 9235694

Hanssen KF (1997)
Blood glucose control and microvascular and macrovascular complications in diabetes
Diabetes, 46 Suppl 2, S101-3
DOI 10.2337/diab.46.2.s101, PubMed 9285509

Publications 1996

Birkeland KI, Rishaug U, Hanssen KF, Vaaler S (1996)
NIDDM: a rapid progressive disease. Results from a long-term, randomised, comparative study of insulin or sulphonylurea treatment
Diabetologia, 39 (12), 1629-33
DOI 10.1007/s001250050626, PubMed 8960854

Birkeland KI, Vaaler S, Hanssen KF (1996)
[Insulin treatment is of value--also in type 2 diabetes]
Tidsskr Nor Laegeforen, 116 (10), 1233-5
PubMed 8658397

Joner G, Hanssen KF (1996)
[May the epidemic of diabetes be stopped?]
Tidsskr Nor Laegeforen, 116 (29), 3449-50
PubMed 9019846

Publications 1995

Bangstad HJ, Hartmann A, Berg TJ, Hanssen KF (1995)
[ACE inhibitors and early diabetic nephropathy]
Tidsskr Nor Laegeforen, 115 (24), 3039-41
PubMed 7570536

Birkeland KI, Hanssen KF, Stranden E, Falch JA, Vaaler S (1995)
Insulin-mediated increase in calf blood flow is not related to blood pressure levels in patients with type 2 diabetes mellitus
Blood Press, 4 (2), 80-4
DOI 10.3109/08037059509077574, PubMed 7599758

Bjørn SF, Bangstad HJ, Hanssen KF, Nyberg G, Walker JD, Viberti GC, Osterby R (1995)
Glomerular epithelial foot processes and filtration slits in IDDM patients
Diabetologia, 38 (10), 1197-204
DOI 10.1007/BF00422369, PubMed 8690172

Claudi T, Midthjell K, Furuset K, Hanssen KF, Hestvold PI, Ogar P (1995)
[The NSAM (Norwegian Society of General Practitioners) treatment program for diabetes in general practice]
Tidsskr Nor Laegeforen, 115 (18), 2301-2
PubMed 7652730

Hanssen KF (1995)
Retningslinjer for behandling av type 1 diabetes
Novo nordisk pharma, Rud, 24 s.
BIBSYS 950894362

Publications 1994

Amthor KF, Dahl-Jørgensen K, Berg TJ, Heier MS, Sandvik L, Aagenaes O, Hanssen KF (1994)
The effect of 8 years of strict glycaemic control on peripheral nerve function in IDDM patients: the Oslo Study
Diabetologia, 37 (6), 579-84
DOI 10.1007/BF00403376, PubMed 7926342

Bangstad HJ, Brinchmann-Hansen O, Hultgren S, Dahl-Jørgensen K, Hanssen KF (1994)
Impaired contrast sensitivity in adolescents and young type 1 (insulin-dependent) diabetic patients with microalbuminuria
Acta Ophthalmol (Copenh), 72 (6), 668-73
DOI 10.1111/j.1755-3768.1994.tb04677.x, PubMed 7747572

Bangstad HJ, Osterby R, Dahl-Jørgensen K, Berg KJ, Hartmann A, Hanssen KF (1994)
Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy
Diabetologia, 37 (5), 483-90
DOI 10.1007/s001250050136, PubMed 8056186

Birkeland KI, Hanssen KF, Urdal P, Berg K, Vaaler S (1994)
A long-term, randomized, comparative study of insulin versus sulfonylurea therapy in type 2 diabetes
J Intern Med, 236 (3), 305-13
DOI 10.1111/j.1365-2796.1994.tb00801.x, PubMed 8077888

Dahl-Jørgensen K, Brinchmann-Hansen O, Bangstad HJ, Hanssen KF (1994)
Blood glucose control and microvascular complications--what do we do now?
Diabetologia, 37 (12), 1172-7
DOI 10.1007/BF00399789, PubMed 7895945

Hanssen KF (1994)
How tight must blood glucose control be to prevent diabetic nephropathy?
Nephrol Dial Transplant, 9 (3), 226-7
PubMed 8052424

Publications 1993

Bangstad HJ, Dahl-Jørgensen K, Kjaersgaard P, Mevold K, Hanssen KF (1993)
Urinary albumin excretion rate and puberty in non-diabetic children and adolescents
Acta Paediatr, 82 (10), 857-62
DOI 10.1111/j.1651-2227.1993.tb17628.x, PubMed 8241647

Bangstad HJ, Osterby R, Dahl-Jørgensen K, Berg KJ, Hartmann A, Nyberg G, Frahm Bjørn S, Hanssen KF (1993)
Early glomerulopathy is present in young, type 1 (insulin-dependent) diabetic patients with microalbuminuria
Diabetologia, 36 (6), 523-9
DOI 10.1007/BF02743268, PubMed 8335174

Birkeland KI, Hanssen KF, Torjesen PA, Vaaler S (1993)
Level of sex hormone-binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetes
J Clin Endocrinol Metab, 76 (2), 275-8
DOI 10.1210/jcem.76.2.8432768, PubMed 8432768

Brinchmann-Hansen O, Bangstad HJ, Hultgren S, Fletcher R, Dahl-Jørgensen K, Hanssen KF, Sandvik L (1993)
Psychophysical visual function, retinopathy, and glycemic control in insulin-dependent diabetics with normal visual acuity
Acta Ophthalmol (Copenh), 71 (2), 230-7
DOI 10.1111/j.1755-3768.1993.tb04996.x, PubMed 8333271

Hanssen KF, Dahl-Jørgensen K, Brinchmann-Hansen O (1993)
[Blood glucose level means everything]
Tidsskr Nor Laegeforen, 113 (23), 2890-1
PubMed 8236187

Publications 1992

Bangstad HJ, Kofoed-Enevoldsen A, Dahl-Jørgensen K, Hanssen KF (1992)
Glomerular charge selectivity and the influence of improved blood glucose control in type 1 (insulin-dependent) diabetic patients with microalbuminuria
Diabetologia, 35 (12), 1165-9
DOI 10.1007/BF00401371, PubMed 1478369

Birkeland KI, Chatzipanagiotou F, Hanssen KF, Vaaler S (1992)
Relationship between blood pressure and in vivo action of insulin in type II (non-insulin-dependent) diabetic subjects
Metabolism, 41 (3), 301-5
DOI 10.1016/0026-0495(92)90275-f, PubMed 1542270

Brinchmann-Hansen O, Dahl-Jørgensen K, Hanssen KF, Sandvik L (1992)
Oscillatory potentials, retinopathy, and long-term glucose control in insulin-dependent diabetes
Acta Ophthalmol (Copenh), 70 (6), 705-12
DOI 10.1111/j.1755-3768.1992.tb04873.x, PubMed 1488874

Brinchmann-Hansen O, Dahl-Jørgensen K, Hanssen KF, Sandvik L (1992)
Macular recovery time, diabetic retinopathy, and clinical variables after 7 years of improved glycemic control
Acta Ophthalmol (Copenh), 70 (2), 235-42
DOI 10.1111/j.1755-3768.1992.tb04130.x, PubMed 1609574

Brinchmann-Hansen O, Dahl-Jørgensen K, Sandvik L, Hanssen KF (1992)
Blood glucose concentrations and progression of diabetic retinopathy: the seven year results of the Oslo study
BMJ, 304 (6818), 19-22
DOI 10.1136/bmj.304.6818.19, PubMed 1734985

Claudi T, Midthjell K, Ogar P, Hestvold PI, Furuseth K, Hanssen KF (1992)
[Quality assurance of cooperation/distribution of work between primary health care and other health services. Using care for diabetics as a basis]
Tidsskr Nor Laegeforen, 112 (28), 3555-9
PubMed 1462326

Dahl-Jørgensen K, Bjøro T, Kierulf P, Sandvik L, Bangstad HJ, Hanssen KF (1992)
Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus
Kidney Int, 41 (4), 920-3
DOI 10.1038/ki.1992.140, PubMed 1513113

Hanssen KF (1992)
[Pregnancy in insulin-dependent diabetic patients]
Nord Med, 107 (8-9), 211-2
PubMed 1383922

Hanssen KF, Bangstad HJ, Brinchmann-Hansen O, Dahl-Jørgensen K (1992)
Blood glucose control and diabetic microvascular complications: long-term effects of near-normoglycaemia
Diabet Med, 9 (8), 697-705
DOI 10.1111/j.1464-5491.1992.tb01876.x, PubMed 1395460

Hanssen KF, Jenssen T (1992)
[Treatment of non-insulin dependent diabetes (type 2 diabetes mellitus)]
Tidsskr Nor Laegeforen, 112 (7), 912-4
PubMed 1557762

Joner G, Brinchmann-Hansen O, Torres CG, Hanssen KF (1992)
A nationwide cross-sectional study of retinopathy and microalbuminuria in young Norwegian type 1 (insulin-dependent) diabetic patients
Diabetologia, 35 (11), 1049-54
DOI 10.1007/BF02221680, PubMed 1473614

Publications 1991

Bangstad HJ, Try K, Dahl-Jørgensen K, Hanssen KF (1991)
New semiquantitative dipstick test for microalbuminuria
Diabetes Care, 14 (11), 1094-7
DOI 10.2337/diacare.14.11.1094, PubMed 1797496

Dahl-Jørgensen K, Joner G, Hanssen KF (1991)
Relationship between cows' milk consumption and incidence of IDDM in childhood
Diabetes Care, 14 (11), 1081-3
DOI 10.2337/diacare.14.11.1081, PubMed 1797491

Hanssen KF, Følling I (1991)
[Treatment of insulin-dependent diabetes]
Tidsskr Nor Laegeforen, 111 (16), 1982-3
PubMed 1866733

Kapelrud H, Bangstad HJ, Dahl-Jørgensen K, Berg K, Hanssen KF (1991)
Serum Lp(a) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria
BMJ, 303 (6804), 675-8
DOI 10.1136/bmj.303.6804.675, PubMed 1833011

Publications 1990

Hanssen KF, Bangstad HJ, Brinchman-Hansen O, Dahl-Jørgensen K (1990)
Glycemic control, incipient diabetic nephropathy, and diabetic retinopathy
J Diabet Complications, 4 (2), 66-7
DOI 10.1016/0891-6632(90)90035-4, PubMed 2145303

Hanssen KF, Hanssen P (1990)
Diabetesboka
Tano, Oslo (2. utg.)
BIBSYS 900214236

Haakens K, Hanssen KF, Dahl-Jørgensen K, Vaaler S, Aagenaes O, Mosand R (1990)
Continuous subcutaneous insulin infusion (CSII), multiple injections (MI) and conventional insulin therapy (CT) in self-selecting insulin-dependent diabetic patients. A comparison of metabolic control, acute complications and patient preferences
J Intern Med, 228 (5), 457-64
DOI 10.1111/j.1365-2796.1990.tb00263.x, PubMed 2254715

Publications 1989

Bangstad HJ, Hanssen KF, Dahl-Jørgensen K, Aagenaes O (1989)
Microalbuminuria is associated with long term poor glycemic control in adolescent insulin dependent diabetics
Diabetes Res, 12 (2), 71-4
PubMed 2634509

Haakens K, Hanssen KF, Dahl-Jørgensen K, Vaaler S, Torjesen P, Try K (1989)
Early morning glycaemia and the metabolic consequences of delaying breakfast/morning insulin. A comparison of continuous subcutaneous insulin infusion and multiple injection therapy with human isophane or human ultralente insulin at bedtime in insulin-dependent diabetics
Scand J Clin Lab Invest, 49 (7), 653-9
DOI 10.3109/00365518909091541, PubMed 2692136

Publications 1988

Bangstad HJ, Dahl-Jørgensen K, Aagenaes O, Hanssen KF, Kierulf P (1988)
[Microalbuminuria. An important marker for diabetic nephropathy and macrovascular disease]
Tidsskr Nor Laegeforen, 108 (26), 2168-70
PubMed 3206421

Brinchmann-Hansen O, Dahl-Jørgensen K, Hanssen KF, Sandvik L (1988)
The response of diabetic retinopathy to 41 months of multiple insulin injections, insulin pumps, and conventional insulin therapy
Arch Ophthalmol, 106 (9), 1242-6
DOI 10.1001/archopht.1988.01060140402041, PubMed 3046587

Brinchmann-Hansen O, Dahl-Jørgensen K, Hanssen KF, Sandvik L (1988)
Effects of intensified insulin treatment on retinal vessels in diabetic patients
Br J Ophthalmol, 72 (9), 666-73
DOI 10.1136/bjo.72.9.666, PubMed 3052571

Brinchmann-Hansen O, Dahl-Jørgensen K, Hanssen KF, Sandvik L (1988)
Oscillatory potentials, macular recovery time, and diabetic retinopathy through 3 years of intensified insulin treatment
Ophthalmology, 95 (10), 1358-66
DOI 10.1016/s0161-6420(88)33010-1, PubMed 3067179

Dahl-Jørgensen K, Hanssen KF (1988)
[Can good blood sugar regulation prevent diabetic complications?]
Nord Med, 103 (12), 343-4
PubMed 3200703

Dahl-Jørgensen K, Hanssen KF, Kierulf P, Bjøro T, Sandvik L, Aagenaes O (1988)
Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. The Oslo Study
Acta Endocrinol (Copenh), 117 (1), 19-25
DOI 10.1530/acta.0.1170019, PubMed 3289293

Hanssen KF, Brinchmann-Hansen O, Dahl-Jørgensen K, Sandvik L (1988)
[Effect of intensive treatment on diabetic retinopathy]
Journ Annu Diabetol Hotel Dieu, 167-73
PubMed 3050220

Hanssen KF, Haakens K, Jervell J, Toverud EL (1988)
[Improvements in insulin therapy]
Tidsskr Nor Laegeforen, 108 (19-21), 1513-5
PubMed 3291195

Haakens K, Hanssen KF (1988)
[Hypoglycemia in children with diabetes mellitus. A frequent problem]
Tidsskr Nor Laegeforen, 108 (25), 2000-3
PubMed 3059558

Kapelrud H, Hanssen KF (1988)
[Risk factors for macrovascular disease in diabetes]
Tidsskr Nor Laegeforen, 108 (26), 2154-6
PubMed 3206418

Rosenlund EF, Haakens K, Brinchmann-Hansen O, Dahl-Jørgensen K, Hanssen KF (1988)
Transient proliferative diabetic retinopathy during intensified insulin treatment
Am J Ophthalmol, 105 (6), 618-25
DOI 10.1016/0002-9394(88)90054-2, PubMed 3287938

Publications 1987

Bangstad HJ, Hanssen KF, Kierulf P, Larsen S, Dahl-Jørgensen K, Joø GB, Aagenaes O (1987)
Elevated albumin excretion rate is common among poorly controlled adolescent insulin dependent diabetics
Diabetes Res, 6 (1), 43-6
PubMed 3690956

Brinchmann-Hansen O, Myhre K, Dahl-Jørgensen K, Hanssen KF, Sandvik L (1987)
The central light reflex of retinal arteries and veins in insulin-dependent diabetic subjects
Acta Ophthalmol (Copenh), 65 (4), 474-80
DOI 10.1111/j.1755-3768.1987.tb07026.x, PubMed 3661146

Dahl-Jørgensen K, Torjesen P, Hanssen KF, Sandvik L, Aagenaes O (1987)
Increase in insulin antibodies during continuous subcutaneous insulin infusion and multiple-injection therapy in contrast to conventional treatment
Diabetes, 36 (1), 1-5
DOI 10.2337/diab.36.1.1, PubMed 3539672

Vaaler S, Bjørneklett A, Jelling I, Skrede G, Hanssen KF, Fausa O, Aagenaes O (1987)
Sorbitol as a sweetener in the diet of insulin-dependent diabetes
Acta Med Scand, 221 (2), 165-70
DOI 10.1111/j.0954-6820.1987.tb01262.x, PubMed 3296669

Publications 1986

Dahl-Jørgensen K, Brinchmann-Hansen O, Hanssen KF, Ganes T, Kierulf P, Smeland E, Sandvik L, Aagenaes O (1986)
Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study
Br Med J (Clin Res Ed), 293 (6556), 1195-9
DOI 10.1136/bmj.293.6556.1195, PubMed 3096429

Gjemdal T, Hanssen KF (1986)
[Non-insulin dependent diabetes--type II diabetes]
Tidsskr Nor Laegeforen, 106 (29), 2412-4
PubMed 3787603

Hanssen KF (1986)
[Diabetes mellitus]
Tidsskr Nor Laegeforen, 106 (29), 2397-9
PubMed 3787599

Hanssen KF, Dahl-Jørgensen K, Lauritzen T, Feldt-Rasmussen B, Brinchmann-Hansen O, Deckert T (1986)
Diabetic control and microvascular complications: the near-normoglycaemic experience
Diabetologia, 29 (10), 677-84
DOI 10.1007/BF00870275, PubMed 3542669

Skare S, Dahl-Jørgensen K, Kriz V, Hanssen KF (1986)
Plasma somatostatin and plasma glucagon in long-term IDDM without residual B-cell function. No effect of different long-term metabolic control
Scand J Clin Lab Invest, 46 (7), 635-8
DOI 10.3109/00365518609083725, PubMed 2878490

Skare S, Hanssen KF, Norman N (1986)
Plasma somatostatin is elevated in primary hypothyroidism compared with hyperthyroidism
Acta Endocrinol (Copenh), 111 (3), 331-5
DOI 10.1530/acta.0.1110331, PubMed 2870598

Skare S, Kriz V, Hanssen KF (1986)
Somatostatin, insulin and glucagon after arginine stimulation in active and treated acromegaly
Acta Endocrinol (Copenh), 111 (2), 145-50
DOI 10.1530/acta.0.1110145, PubMed 2869632

Vaaler S, Hanssen KF, Dahl-Jørgensen K, Frølich W, Aaseth J, Odegaard B, Aagenaes O (1986)
Diabetic control is improved by guar gum and wheat bran supplementation
Diabet Med, 3 (3), 230-3
DOI 10.1111/j.1464-5491.1986.tb00750.x, PubMed 3030619

Publications 1985

Brinchmann-Hansen O, Dahl-Jørgensen K, Hanssen KF, Sandvik L (1985)
Effects of intensified insulin treatment on various lesions of diabetic retinopathy
Am J Ophthalmol, 100 (5), 644-53
DOI 10.1016/0002-9394(85)90618-x, PubMed 3904464

Dahl-Jørgensen K, Brinchmann-Hansen O, Hanssen KF, Sandvik L, Aagenaes O (1985)
Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study
Br Med J (Clin Res Ed), 290 (6471), 811-5
DOI 10.1136/bmj.290.6471.811, PubMed 3919804

Hanssen KF, Dahl-Jørgensen K, Brinchmann-Hansen O (1985)
The influence of strict control on diabetic complications
Acta Endocrinol Suppl (Copenh), 272, 57-60
DOI 10.1530/acta.0.110s057, PubMed 3914805

Jørgensen H, Skare S, Frey H, Hanssen KF, Norman N (1985)
Effects of synthetic corticotropin-releasing factor in normal individuals and in patients with hypothalamic-pituitary-adrenocortical disorders
Acta Med Scand, 218 (1), 79-84
DOI 10.1111/j.0954-6820.1985.tb08829.x, PubMed 2996312

Skare S, Dahl-Jørgensen K, Hanssen KF, Norman N (1985)
Increased peripheral venous somatostatin concentration and decreased glucagon response to arginine in patients with insulin dependent diabetes mellitus without residual B-cell function. Increased plasma SRIF in IDDM
Acta Endocrinol (Copenh), 109 (4), 517-21
DOI 10.1530/acta.0.1090517, PubMed 2863913

Publications 1984

Dahl-Jørgensen K, Hanssen KF, Aagenaes O, Haider T (1984)
[Determination of urinary glucose. Simple determination of urinary glucose with a new semi-quantitative reagent stick; the Diabur Test 5000]
Tidsskr Nor Laegeforen, 104 (26), 1803-6
PubMed 6495272

Dahl-Jørgensen K, Hanssen KF, Aagenaes O, Larsen S (1984)
[New methods for subcutaneous insulin administration. A year's experience with the insulin pump and multiple insulin injection therapy]
Tidsskr Nor Laegeforen, 104 (13), 856-61
PubMed 6379982

Hanssen KF, Hanssen P (1984)
Diabetesboka
Tanum-Norli, Oslo, 135 s.
BIBSYS 845002872, ISBN 82-518-1817-6

Skare S, Hanssen KF, Kriz V, Torjesen PA (1984)
Arginine infusion increases peripheral plasma somatostatin in man
Clin Endocrinol (Oxf), 21 (3), 299-308
DOI 10.1111/j.1365-2265.1984.tb03473.x, PubMed 6148165

Vaaler S, Hanssen KF, Aagenaes O (1984)
The effect of cooking upon the blood glucose response to ingested carrots and potatoes
Diabetes Care, 7 (3), 221-3
DOI 10.2337/diacare.7.3.221, PubMed 6734389

Publications 1983

Dolva LO, Hanssen KF, Flaten O, Hanssen LE, von Schenck H (1983)
The effect of thyrotrophin-releasing hormone (TRH) on pancreatic hormone secretion in normal subjects
Acta Endocrinol (Copenh), 102 (2), 224-30
DOI 10.1530/acta.0.1020224, PubMed 6131565

Dolva LO, Hanssen KF, Aadland E, Sand T (1983)
Thyrotropin-releasing hormone immunoreactivity in the gastrointestinal tract of man
J Clin Endocrinol Metab, 56 (3), 524-9
DOI 10.1210/jcem-56-3-524, PubMed 6401759

Dolva LO, Nielsen JH, Welinder BS, Hanssen KF (1983)
Biosynthesis and release of thyrotropin-releasing hormone immunoreactivity in rat pancreatic islets in organ culture. Effects of age, glucose, and streptozotocin
J Clin Invest, 72 (6), 1867-73
DOI 10.1172/JCI111149, PubMed 6227632

Publications 1982

Dolva LO, Hanssen KF (1982)
Thyrotropin-releasing hormone: distribution and actions in the gastrointestinal tract
Scand J Gastroenterol, 17 (6), 705-7
DOI 10.3109/00365528209181082, PubMed 6818681

Dolva LO, Hanssen KF, Flaten O, Skare S, Schrumpf E (1982)
Effect of thyrotropin-releasing hormone on gastric acid secretion in man
Scand J Gastroenterol, 17 (6), 775-80
DOI 10.3109/00365528209181092, PubMed 6818683

Dolva LO, Stadaas J, Hanssen KF (1982)
Effect of thyrotropin-releasing hormone and atropine on the gastric motility stimulated by insulin-induced hypoglycemia
Scand J Gastroenterol, 17 (6), 769-73
DOI 10.3109/00365528209181091, PubMed 6818682

Frey H, Falch J, Hanssen K, Jørgensen H, Vaagen S, Rosenlund B, Torjesen P, Gautvik K (1982)
[Biochemical diagnosis of primary hyperparathyroidism]
Tidsskr Nor Laegeforen, 102 (28), 1441-6
PubMed 6301096

Hanssen KF, Norman N, Nesbakken R (1982)
[Treatment of prolactin producing hypophyseal tumors]
Tidsskr Nor Laegeforen, 102 (24), 1222-5
PubMed 7167893

Publications 1981

Hanssen KF, Dahl-Jørgensen K, Abyholm AS (1981)
[Diabetic control. Self control of urinary and blood glucose and measurement of glycosylated hemoglobin (HbA1)]
Tidsskr Nor Laegeforen, 101 (13), 780-4
PubMed 7268712

Hanssen KF, Søvik O (1981)
[Diabetic treatment - a medical and pedagogical challenge]
Tidsskr Nor Laegeforen, 101 (13), 765-6
PubMed 7268708

Hanssen KF, Torjesen PA, Heding LG (1981)
[Diagnosis of insulinomas. Determination of insulin, C-peptide and proinsulin in blood to differentiate between endogenous and exogenous hyperinsulinism]
Tidsskr Nor Laegeforen, 101 (34-36), 1957-60
PubMed 6280336

Publications 1980

Dahl-Jørgensen K, Meen HD, Hanssen KF, Aagenaes O (1980)
The effect of exercise on diabetic control and hemoglobin A1 (HbA1) in children
Acta Paediatr Scand Suppl, 283, 53-6
DOI 10.1111/j.1651-2227.1980.tb15313.x, PubMed 6938115

Dolva LO, Hanssen KF (1980)
[Hypothalamic disorders. Causes in various clinical symptoms]
Tidsskr Nor Laegeforen, 100 (24), 1421-5
PubMed 7444885

Skare S, Hanssen KF, Lundqvist G (1980)
Increased plasma pancreatic polypeptide (PP) in diabetic ketoacidosis; normalization following treatment
Acta Endocrinol (Copenh), 93 (4), 466-9
DOI 10.1530/acta.0.0930466, PubMed 6770568

Vatn MH, Schrumpf E, Hanssen KF, Myren J (1980)
A small dose of somatostatin inhibits the secretin stimulated secretion of bicarbonate, amylase, and chymotrypsin in man
J Endocrinol Invest, 3 (3), 279-82
DOI 10.1007/BF03348276, PubMed 6159391

Vaaler S, Hanssen KF, Aagenaes O (1980)
Effect of different kinds of fibre on postprandial blood glucose in insulin-dependent diabetics
Acta Med Scand, 208 (5), 389-91
DOI 10.1111/j.0954-6820.1980.tb01218.x, PubMed 6257055

Vaaler S, Hanssen KF, Aagenaes O (1980)
Sucrose and sorbitol as sweeteners in the diet of insulin-dependent diabetics
Acta Med Scand, 207 (5), 371-3
DOI 10.1111/j.0954-6820.1980.tb09740.x, PubMed 6992517

Vaaler S, Hanssen KF, Aagenaes O (1980)
Plasma glucose and insulin responses to orally administered carbohydrate-rich foodstuffs
Nutr Metab, 24 (3), 168-75
DOI 10.1159/000176338, PubMed 7003441

Publications 1979

Dolva LO, Hanssen KF, Berstad A (1979)
Actions of thyrotropin-releasing hormone on the gastrointestinal function in man. II. Inhibition of pentagastrin-stimulated acid secretion
Scand J Gastroenterol, 14 (1), 33-4
DOI 10.3109/00365527909179843, PubMed 106463

Dolva LO, Hanssen KF, Berstad A, Frey HM (1979)
Thyrotrophin-releasing hormone inhibits the pentagastrin stimulated gastric secretion in man. A dose response study
Clin Endocrinol (Oxf), 10 (3), 281-6
DOI 10.1111/j.1365-2265.1979.tb02082.x, PubMed 110504

Eivindson A, Hanssen KF, Moberg Kallings I (1979)
[Legionnaires' disease: a new severe type of pneumonia]
Tidsskr Nor Laegeforen, 99 (29), 1442-4
PubMed 516015

Kulseng-Hanssen S, Torjesen PA, Hanssen KF (1979)
Serum prolactin and thyroid stimulating hormone levels following thyreotropin releasing hormone stimulation in preeclamptic patients
Acta Obstet Gynecol Scand, 58 (3), 245-8
DOI 10.3109/00016347909154042, PubMed 113978

Publications 1978

Dolva O, Hanssen KF, Frey HM (1978)
Actions of thyrotropin-releasing-hormone on gastrointestinal function in man. I. Inhibition of glucose and xylose absorption from the gut
Scand J Gastroenterol, 13 (5), 599-604
DOI 10.3109/00365527809181770, PubMed 100866

Evensen D, Hanssen KF, Berstad A (1978)
The effect on intestinal calcium absorption of somatostatin in man
Scand J Gastroenterol, 13 (4), 449-51
DOI 10.3109/00365527809181920, PubMed 675155

Evensen D, Hanssen KF, Berstad A (1978)
Inhibition of intestinal calcium absorption by somatostatin in man
Metabolism, 27 (9 Suppl 1), 1345-7
DOI 10.1016/0026-0495(78)90071-9, PubMed 682999

Hanssen KF (1978)
[Diabetes mellitus]
Tidsskr Nor Laegeforen, 98 (7-8), 391-3
PubMed 635876

Hanssen KF, Christensen SE, Hansen AP, Lundbaek K, Torjesen PA, Weeke J (1978)
Plasma prolactin in juvenile diabetics. 24-h studies with somatostatin
Diabetologia, 15 (5), 369-71
DOI 10.1007/BF01219645, PubMed 570136

Hanssen O, Hanssen P, Hanssen KF (1978)
Sukkersyke
Tanum-Norli, Oslo (13. utg.), 102 s.
BIBSYS 061819271, ISBN 82-518-0407-8

Hanssen O, Hanssen P, Hanssen KF (1978)
Sukkersyke
Tanum-Norli, Oslo (13. utg.), 102 s.
BIBSYS 921288697

Schrumpf E, Vatn MH, Hanssen KF, Myren J (1978)
A small dose of somatostatin inhibits the pentagastrin stimulated gastric secretion of acid, pepsin and intrinsic factor in man
Clin Endocrinol (Oxf), 8 (5), 391-5
DOI 10.1111/j.1365-2265.1978.tb02173.x, PubMed 348347

Stadaas JO, Schrumpf E, Hanssen KF (1978)
Somatostatin inhibits gastric motility in response to distention
Scand J Gastroenterol, 13 (2), 145-8
DOI 10.3109/00365527809181740, PubMed 635455

Publications 1977

Hanssen KF, Torjesen PA (1977)
Increased serum prolactin in diabetic ketoacidosis; correlation between serum sodium and serum prolacting concentration
Acta Endocrinol (Copenh), 85 (2), 372-8
DOI 10.1530/acta.0.0850372, PubMed 17257

Hanssen LE, Hanssen KF, Myren J (1977)
Inhibition of secretin release and pancreatic bicarbonate secretion by somatostatin infusion in man
Scand J Gastroenterol, 12 (4), 391-4
DOI 10.3109/00365527709181678, PubMed 18787

Melsom H, Indrebo T, Hanssen KF (1977)
[Alcoholic acidosis]
Tidsskr Nor Laegeforen, 97 (33), 1753-4
PubMed 594979

Vatn MH, Schrumpf E, Hanssen KF, Myren J (1977)
The effect of somatostatin on pentagastrin-stimulated gastric secretion and on plasma gastrin in man
Scand J Gastroenterol, 12 (7), 833-9
DOI 10.3109/00365527709181727, PubMed 339322

Publications 1976

Hanssen O, Hanssen P, Hanssen KF (1976)
Sukkersyke
Tanum-Norli, Oslo (12. omarb. utg.), 93 s.
BIBSYS 90092005x, ISBN 82-518-0407-8

Schrumpf E, Vatn MH, Hanssen KF, Semb LS, Myren J (1976)
The effect of somatostatin on gastrin release and gastric secretion
Scand J Gastroenterol Suppl, 42, 41-2
PubMed 1070794

Schrumpf E, Vatn MH, Hanssen KF, Semb S, Myren J (1976)
Somatostatin inhibits insulin-stimulated gastrin release and gastric secretion of acid, pepsin, and intrinsic factor (IF) in duodenal ulcer patients
Scand J Gastroenterol, 11 (5), 517-20
PubMed 785589

Publications 1975

Hanssen KF (1975)
Urinary growth hormone: Determination and relationship to plasma growth hormone in insulin treated diabetes mellitus, acromegaly and growth retardation in children
Steno Memorial Hospital & Research Laboratory, Gentofte ;Copenhagen and Children's Hospital, Fuglebakken, Copenhagen, Oslo,
BIBSYS 980006147

Publications 1974

Besser GM, Mortimer CH, McNeilly AS, Thorner MO, Batistoni GA, Bloom SR, Kastrup KW, Hanssen KF, Hall R, Coy DH, Kastin AJ, Schally AV (1974)
Long-term infusion of growth hormone release inhibiting hormone in acromegaly: effects on pituitary and pancreatic hormones
Br Med J, 4 (5945), 622-7
DOI 10.1136/bmj.4.5945.622, PubMed 4374289

Hanssen KF (1974)
Immunoreactive growth hormone in plasma and urine in juvenile diabetics before and during initial insulin treatment
Acta Endocrinol (Copenh), 75 (1), 50-63
DOI 10.1530/acta.0.0750050, PubMed 4406481

Hanssen KF (1974)
Immunoreactive growth hormone in plasma and urine in long term insulin treated diabetics in relation to diabetic retinopathy
Acta Endocrinol (Copenh), 75 (1), 64-74
DOI 10.1530/acta.0.0750064, PubMed 4406482

Hanssen KF, Rasmussen P (1974)
Urinary growth hormone in acromegaly
Acta Med Scand, 195 (5), 381-4
DOI 10.1111/j.0954-6820.1974.tb08156.x, PubMed 4830054

Hanssen KF, Svendsen PA, Evrin PE (1974)
Immunoreactive growth hormone in plasma and urine in long term insulin treated diabetics with clinical diabetic nephropathy
Acta Endocrinol (Copenh), 75 (1), 75-86
DOI 10.1530/acta.0.0750075, PubMed 4406483

Publications 1972

Hanssen KF (1972)
Radioimmunoassay of growth hormone in human plasma. Methodological studies and plasma immunoreactive growth hormone concentration during insulin induced hypoglycaemia in normal children and adults
Acta Endocrinol (Copenh), 71 (4), 649-64
PubMed 4678203

Hanssen KF (1972)
Immunoreactive growth hormone in human urine
Acta Endocrinol (Copenh), 71 (4), 665-76
DOI 10.1530/acta.0.0710665, PubMed 4678204

Hanssen KF, Asfeldt VH (1972)
Human growth hormone secretion during major surgical stress and the influence of pre-treatment with dexamethasone
Horm Metab Res, 4 (1), 57
DOI 10.1055/s-0028-1097081, PubMed 5011078